|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 4.140 USD | +1.22% |
|
+2.48% | +75.42% |
| 09-29 | Craig-Hallum Upgrades Rezolute to Buy From Hold, Price Target is $7 | MT |
| 09-24 | Rezolute Fiscal Q4 Loss Narrows | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REZOLUTE, INC. | Bio Therapeutic Drugs | +1.22% | +2.48% | +75.42% | -55.44% | -44.43% | 429M |  |  | |
- Stock Market
- Stocks
- RZLT Stock
- Charts Rezolute, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
